Phase I study of sorafenib plus ifosfamide in patients with advanced soft tissue and bone sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.

被引：0
|
作者：
Garcia del Muro, X.
Lopez-Pousa, A.
Martin Broto, J.
Cubedo, R.
Jimenez Colomo, L.
Gallego, O.
Prevencio-Pulla, M.
机构：
[1] Inst Catalan Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[3] Hosp Son Dureta, Palma De Mallorca, Spain
[4] Hosp Puerta de Hierro, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10024
引用
收藏
页数：1
相关论文
共 50 条
  • [41] DOXORUBICIN PLUS IFOSFAMIDE WITH RHGM-CSF IN THE TREATMENT OF ADVANCED ADULT SOFT-TISSUE SARCOMAS - PRELIMINARY-RESULTS OF A PHASE-II STUDY FROM THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    STEWARD, WP
    VERWEIJ, J
    SOMERS, R
    BLACKLEDGE, G
    CLAVEL, M
    VANOOSTEROM, AT
    GREIFENBERG, B
    SOEDIRMAN, J
    THOMAS, D
    VANGLABBEKE, M
    KELLY, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1991, 117 : S193 - S197
  • [42] Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I
    Martinez-Trufero, Javier
    Jurado, Josefina Cruz
    Gomez-Mateo, M. Carmen
    Bernabeu, Daniel
    Floria, Luis Javier
    Lavernia, Javier
    Sebio, Ana
    del Muro, Xavier Garcia
    Alvarez, Rosa
    Correa, Raquel
    Hernandez-Leon, C. Nieves
    Marquina, Gloria
    Hindi, Nadia
    Redondo, Andres
    Martinez, Virginia
    Asencio, Jose Manuel
    Mata, Cristina
    Morales, Claudia M. Valverde
    Martin-Broto, Javier
    CANCER TREATMENT REVIEWS, 2021, 99
  • [43] Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study
    Martin-Broto, Javier
    Lopez Pousa, Antonio
    de las Penas, Ramon
    Garcia del Muro, Xavier
    Gutierrez, Antonio
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa
    Cubedo, Ricardo
    Redondo, Andres
    Maurel, Joan
    Carrasco, Juan A.
    Lopez-Martin, Jose A.
    Sala, Angeles
    Andres Meana, Jose
    Ramos, Rafael
    Martinez-Serra, Jordi
    Lopez-Guerrero, Jose A.
    Sevilla, Isabel
    Balana, Carmen
    Vaz, Angeles
    De Juan, Ana
    Alemany, Regina
    Poveda, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2294 - +
  • [44] Retrospective analysis of surgery in metastatic GIST patients sensitive to imatinib: A Spanish Group for Research on Sarcoma (GEIS) study.
    Rubio, J.
    Martinez-Trufero, J.
    Lopez-Pousa, A.
    Garcia del Muro, X.
    Fra, J.
    Redondo, A.
    Lainez, N.
    Poveda, A.
    Casado, A.
    Valverde, C. M.
    De Juan, A.
    Sevilla, I.
    Andres, R.
    Cruz, J.
    Safont, M. J.
    Martin Broto, J.
    Garcia-Albeniz, X.
    Maurel, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Chawla, Sant P.
    Staddon, Arthur
    Hendifar, Andrew
    Messam, Conrad A.
    Patwardhan, Rita
    Kamel, Yasser Mostafa
    BMC CANCER, 2013, 13
  • [46] Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
    Sant P Chawla
    Arthur Staddon
    Andrew Hendifar
    Conrad A Messam
    Rita Patwardhan
    Yasser Yasser Mostafa Kamel
    BMC Cancer, 13
  • [47] Update of phase I study of imatinib (ST1571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
    van Oosterom, AT
    Judson, IR
    Verweij, J
    Stroobants, S
    Dumez, H
    di Paola, ED
    Sciot, R
    Van Glabbeke, M
    Dimitrijevic, S
    Nielsen, OS
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S87
  • [48] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
  • [49] Phase II study of ET-743 in advanced soft tissue sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial
    Le Cesne, A
    Blay, JY
    Judson, I
    Van Oosterom, A
    Verweij, J
    Radford, J
    Lorigan, P
    Rodenhuis, S
    Ray-Coquard, I
    Bonvalot, S
    Collin, F
    Jimeno, J
    Di Paola, E
    Van Glabbeke, M
    Nielsen, OS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 576 - 584
  • [50] Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II
    Martinez-Trufero, Javier
    Jurado, Josefina Cruz
    Hernandez-Leon, C. Nieves
    Correa, Raquel
    Asencio, Jose Manuel
    Bernabeu, Daniel
    Alvarez, Rosa
    Hindi, Nadia
    Mata, Cristina
    Marquina, Gloria
    Martinez, Virginia
    Redondo, Andres
    Floria, Luis Javier
    Gomez-Mateo, M. Carmen
    Lavernia, Javier
    Sebio, Ana
    del Muro, Xavier Garcia
    Martin-Broto, Javier
    Valverde-Morales, Claudia
    CANCER TREATMENT REVIEWS, 2021, 99
12345